YOLO
2
Acquiring generic competitors in the USA, Europe and Japan • Generics win market share on price. Given the small margins, companies need to focus on economies of scale and ensure that they have a robust and cost-effective manufacturing capacity. – 2008, purchased US-based Barr(fourth-largest generics company globally) – 2010, purchased ratiopharm, extensive reach in EU and Eastern Europe.
description
yolo
Transcript of YOLO
Acquiring generic competitors in the USA, Europe and Japan
Acquiring generic competitors in the USA, Europe and JapanGenerics win market share on price. Given the small margins, companies need to focus on economies of scale and ensure that they have a robust and cost-effective manufacturing capacity.2008, purchased US-based Barr(fourth-largest generics company globally)2010, purchased ratiopharm, extensive reach in EU and Eastern Europe.
The move away from generics into research-based pharmaceuticals and over-the couter medicines2011, acquire Cephalon, a research-based pharmaceutical company.Joint venture with Procter and Gamble to create PTG Health headquartered in Geneve, Switzerland.
